CGTX
NASDAQ · Pharmaceuticals
Cognition Therapeutics Inc
$1.07
-0.01 (-0.93%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,793.5% upside
Low Target
$22.83
Average Target
$30.96
High Target
$36.58
Current Price
$1.07
Current
$1.07
$1.07
Target
$30.96
$30.96
$22.83
$30.96 avg
$36.58
Scenario Analysis
Bear Case
$22.83
2,033.6%
Low target
Base Case
$30.96
+2,793.5%
Avg target
Bull Case
$36.58
+3,318.7%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$3.83
-72.1% from high
52-Week Low
$0.22
+381.3% from low
Target vs 52W High
$30.96
+708.4% vs high
Next Earnings Report
Mar 26, 2026 · Before Market Open
Today
EPS Est: $-0.09
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |